XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Net Loss Per Share
The following table outlines the basic and diluted net loss per share for the three months ended March 31, 2024 and 2023:

 Three Months Ended March 31,
(in thousands, except per share data)20242023
Net loss$(18,961)$(6,100)
Weighted-average shares outstanding, basic and diluted100,755 99,158 
Net loss per share, basic and diluted$(0.19)$(0.06)
Summary of Dilutive Common Shares
The following table outlines dilutive common share equivalents outstanding, which are excluded in the above diluted net loss per share calculation, as the effect of their inclusion would be anti-dilutive, or the share equivalents were contingently issuable as of each period presented:

 March 31,
20242023
Options to purchase common stock issued and outstanding(1)
22,437,492 18,735,538 
Earnout shares16,292,542 16,292,542 
Avista private placement warrants8,233,333 8,233,333 
Avista public warrants7,666,667 7,666,667 
Restricted stock units issued and outstanding(1)
2,421,767 1,710,065 
Forward purchase warrants1,666,667 1,666,667 
Backstop warrants1,445,489 1,445,489 
Shares expected to be purchased under employee stock purchase plan946,670 1,918,512 
Total anti-dilutive shares61,110,627 57,668,813 
_____________
(1)Outstanding stock options and restricted stock units include awards outstanding to employees of Ligand.